For the year ending 2025-12-31, BMRN has $7,594,022K in assets. $1,507,023K in debts. $1,311,679K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,311,679 | 942,842 | 755,127 | 724,531 |
| Short-term investments | 248,930 | 194,864 | 318,683 | 567,006 |
| Accounts receivable, net | 908,214 | 660,535 | 633,704 | 461,316 |
| Inventory | 1,298,883 | 1,232,653 | 1,107,183 | 894,083 |
| Other current assets | 185,784 | 201,533 | 141,391 | 104,521 |
| Total current assets | 3,953,490 | 3,232,427 | 2,956,088 | 2,751,457 |
| Long-term investments | 492,242 | 521,238 | 611,135 | 333,835 |
| Property, plant and equipment, net | 952,508 | 1,043,041 | 1,066,133 | 1,073,366 |
| Intangible assets, net | 213,837 | 255,278 | 294,701 | 338,569 |
| Goodwill | 196,199 | 196,199 | 196,199 | 196,199 |
| Deferred tax assets | 1,508,697 | 1,489,366 | 1,545,809 | 1,505,412 |
| Other assets | 277,049 | 251,391 | 171,538 | 176,236 |
| Total assets | 7,594,022 | 6,988,940 | 6,841,603 | 6,375,074 |
| Accounts payable and accrued liabilities | 759,031 | 606,988 | 683,147 | 572,959 |
| Short-term convertible debt, net | - | 0 | 493,877 | - |
| Short-term contingent consideration | - | - | 0 | 15,925 |
| Total current liabilities | 759,031 | 606,988 | 1,177,024 | 588,884 |
| Long-term convertible debt, net | 597,176 | 595,138 | 593,095 | 1,083,019 |
| Long-term contingent consideration | - | - | - | 0 |
| Other long-term liabilities | 150,816 | 128,824 | 119,935 | 100,015 |
| Total liabilities | 1,507,023 | 1,330,950 | 1,890,054 | 1,771,918 |
| Common stock, 0.001 par value 500,000,000 shares authorized 192,300,101 and 190,761,349 shares issued and outstanding, respectively | 192 | 191 | 189 | 186 |
| Additional paid-in capital | 5,956,582 | 5,802,068 | 5,611,562 | 5,404,895 |
| Company common stock held by the nonqualified deferred compensation plan | 10,508 | 11,227 | 9,860 | 8,859 |
| Accumulated other comprehensive income (loss) | -13,473 | 61,653 | -28,788 | -3,867 |
| Retained earnings (accumulated deficit) | 154,206 | -194,695 | -621,554 | -789,199 |
| Total stockholders equity | 6,086,999 | 5,657,990 | 4,951,549 | 4,603,156 |
| Total liabilities and stockholders equity | 7,594,022 | 6,988,940 | 6,841,603 | 6,375,074 |
BIOMARIN PHARMACEUTICAL INC (BMRN)
BIOMARIN PHARMACEUTICAL INC (BMRN)